Works matching IS 10685308 AND DT 2011 AND VI 22 AND IP 2
Results: 10
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 2, p. 8
- Publication type:
- Article
Risperidone long-acting injection in Huntington's disease.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 2, p. 8
- Publication type:
- Article
Residual effects of zolpidem on next-day driving.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 2, p. 8
- Publication type:
- Article
Antidepressant efficacy for MDD and comorbid Axis III disorders.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 2, p. 7
- Publication type:
- Article
Risperidone LAI for schizophrenia relapse prevention.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 2, p. 7
- Publication type:
- Article
FDA proposes plan to reduce opioid abuse.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 2, p. 4
- Publication type:
- Article
Dextromethorphan plus quinidine to be approved for pseudobulbar affect.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 2, p. 1
- Publication type:
- Article
DHA supplements during pregnancy for postpartum depression not effective.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 2, p. 1
- Publication type:
- Article
DHA supplementation fails to slow dementia.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 2, p. 3
- Publication type:
- Article
Effects of duloxetine on antipsychotic drug concentrations.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 2, p. 2
- By:
- Publication type:
- Article